Temozolomide con o senza capecitabina nel trattamento di pazienti con tumori neuroendocrini pancreatici avanzati
Uno studio randomizzato di fase II su temozolomide o temozolomide e capecitabina in pazienti con tumori neuroendocrini pancreatici avanzati
This randomized phase II trial studies how well giving temozolomide with or without capecitabine works in treating patients with advanced pancreatic neuroendocrine tumors. Drugs used in chemotherapy, such as temozolomide and capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether temozolomide is more effective with or without capecitabine in treating patients with advanced pancreatic neuroendocrine tumors.
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Intervento / Trattamento
Intervento / Trattamento
Descrizione dettagliata
PRIMARY OBJECTIVES:
I. To evaluate progression-free survival (PFS) associated with temozolomide alone or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors.
SECONDARY OBJECTIVES:
I. To evaluate response rates (RR) associated with temozolomide alone or temozolomide and capecitabine treatment in patients with advanced pancreatic neuroendocrine tumors.
II. To evaluate overall survival (OS) associated with temozolomide alone or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors.
III. To evaluate the toxicity associated with temozolomide alone or temozolomide and capecitabine treatment in patients with advanced pancreatic neuroendocrine tumors.
IV. To evaluate the usefulness of methyl guanine methyltransferase (MGMT) status (by immunohistochemistry [IHC] and promoter methylation) for predicting response in pancreatic neuroendocrine tumor patients treated with either temozolomide or temozolomide and capecitabine.
V. To bank radiology images for evaluation of quality, reproducibility, and compliance with computed tomography (CT) methodology.
OUTLINE: Patients are randomized to 1 of 2 treatment arms.
ARM A: Patients receive temozolomide orally (PO) once daily (QD) on days 1-5. Treatment repeats every 28 days for up to 13 courses in the absence of disease progression or unacceptable toxicity.
ARM B: Patients receive capecitabine PO twice daily (BID) on days 1-14 and temozolomide PO QD on days 10-14. Treatment repeats every 28 days for up to 13 courses in the absence of disease progression or unacceptable toxicity.
After completion of study treatment, patients are followed up every 3 months for 2 years, and then every 6 months for 3 years.
Tipo di studio
Tipo di studio
Iscrizione (Effettivo)
Iscrizione
Fase
Fase
- Fase 2
Contatti e Sedi
Luoghi di studio
-
-
California
-
Anaheim, California, Stati Uniti, 92807
- Kaiser Anaheim Medical Center
-
Antioch, California, Stati Uniti, 94531
- Kaiser Permanente-Deer Valley Medical Center
-
Baldwin Park, California, Stati Uniti, 91706
- Kaiser Permanente Medical Group - Baldwin Park
-
Bellflower, California, Stati Uniti, 90706
- Kaiser Foundation Hospital
-
Berkeley, California, Stati Uniti, 94704
- Alta Bates Summit Medical Center-Herrick Campus
-
Burlingame, California, Stati Uniti, 94010
- Mills - Peninsula Hospitals
-
Fontana, California, Stati Uniti, 92335
- Kaiser Permanente Hospital
-
Fremont, California, Stati Uniti, 94538
- Kaiser Permanente, Fremont
-
Fresno, California, Stati Uniti, 93720
- Kaiser Permanente
-
Harbor City, California, Stati Uniti, 90710
- Kaiser Permanente - Harbor City
-
Hayward, California, Stati Uniti, 94545
- Kaiser Permanente, Hayward
-
Irvine, California, Stati Uniti, 92618
- Southern California Permanente Medical Group
-
Los Angeles, California, Stati Uniti, 90048
- Cedars-Sinai Medical Center
-
Los Angeles, California, Stati Uniti, 90027
- Kaiser Permanente Los Angeles Medical Center
-
Los Angeles, California, Stati Uniti, 90033
- University of Southern California/Norris Cancer Center
-
Los Angeles, California, Stati Uniti, 90034
- Kaiser Permanente-West Los Angeles
-
Modesto, California, Stati Uniti, 95356
- Kaiser Permanente-Modesto
-
Novato, California, Stati Uniti, 94945
- Sutter Cancer Research Consortium
-
Oakland, California, Stati Uniti, 94611
- Kaiser Permanente-Oakland
-
Orange, California, Stati Uniti, 92868
- University of California Medical Center At Irvine-Orange Campus
-
Panorama City, California, Stati Uniti, 91402
- Kaiser Permanente - Panorama City
-
Redwood City, California, Stati Uniti, 94063
- Kaiser Permanente-Redwood City
-
Richmond, California, Stati Uniti, 94801
- Kaiser Permanente-Richmond
-
Riverside, California, Stati Uniti, 92505
- Kaiser Permanente Medical Center
-
Roseville, California, Stati Uniti, 95661
- Kaiser Permanente-Roseville
-
Sacramento, California, Stati Uniti, 95823
- Kaiser Permanente-South Sacramento
-
Sacramento, California, Stati Uniti, 95825
- Kaiser Permanente - Sacramento
-
San Diego, California, Stati Uniti, 92120
- Kaiser Permanente at San Diego
-
San Diego, California, Stati Uniti, 92120
- Kaiser Permanente
-
San Francisco, California, Stati Uniti, 94115
- Kaiser Permanente-San Francisco
-
San Francisco, California, Stati Uniti, 94118
- California Pacific Medical Center
-
San Francisco, California, Stati Uniti, 94115
- UCSF-Mount Zion
-
San Jose, California, Stati Uniti, 95119
- Kaiser Permanente-Santa Teresa-San Jose
-
San Marcos, California, Stati Uniti, 92069
- Kaiser Permanente Health Care
-
San Rafael, California, Stati Uniti, 94903
- Kaiser Permanente-San Rafael
-
Santa Clara, California, Stati Uniti, 95051
- Kaiser Permanente Medical Center - Santa Clara
-
Santa Rosa, California, Stati Uniti, 95403
- Kaiser Permanente-Santa Rosa
-
Santa Rosa, California, Stati Uniti, 95403
- Sutter Pacific Medical Foundation
-
South San Francisco, California, Stati Uniti, 94080
- Kaiser Permanente-South San Francisco
-
Stanford, California, Stati Uniti, 94305
- Stanford University Hospitals and Clinics
-
Stockton, California, Stati Uniti, 95210
- Kaiser Permanente-Stockton
-
Vacaville, California, Stati Uniti, 95688
- Kaiser Permanente Medical Center-Vacaville
-
Vallejo, California, Stati Uniti, 94589
- Kaiser Permanente-Vallejo
-
Vallejo, California, Stati Uniti, 94589
- Sutter Solano Medical Center
-
Walnut Creek, California, Stati Uniti, 94596
- Kaiser Permanente-Walnut Creek
-
Woodland Hills, California, Stati Uniti, 91367
- Kaiser Permanente
-
-
Connecticut
-
Hartford, Connecticut, Stati Uniti, 06105
- Saint Francis Hospital and Medical Center
-
Middletown, Connecticut, Stati Uniti, 06457
- Middlesex Hospital
-
-
Delaware
-
Lewes, Delaware, Stati Uniti, 19958
- Beebe Medical Center
-
Newark, Delaware, Stati Uniti, 19713
- Helen F Graham Cancer Center
-
Newark, Delaware, Stati Uniti, 19713
- Delaware Clinical and Laboratory Physicians PA
-
Newark, Delaware, Stati Uniti, 19713
- Medical Oncology Hematology Consultants PA
-
Newark, Delaware, Stati Uniti, 19718
- Christiana Care Health System-Christiana Hospital
-
Newark, Delaware, Stati Uniti, 19713
- Christiana Gynecologic Oncology LLC
-
Newark, Delaware, Stati Uniti, 19713
- Regional Hematology and Oncology PA
-
Rehoboth Beach, Delaware, Stati Uniti, 19971
- Beebe Health Campus
-
Seaford, Delaware, Stati Uniti, 19973
- Nanticoke Memorial Hospital
-
Wilmington, Delaware, Stati Uniti, 19801
- Christiana Care Health System-Wilmington Hospital
-
-
Florida
-
Jacksonville, Florida, Stati Uniti, 32207
- Edna Williams Cancer Center at the Baptist Cancer Institute
-
Miami, Florida, Stati Uniti, 33136
- University of Miami Miller School of Medicine-Sylvester Cancer Center
-
Orlando, Florida, Stati Uniti, 32803
- Florida Hospital
-
Tampa, Florida, Stati Uniti, 33612
- H. Lee Moffitt Cancer Center and Research Institute
-
-
Hawaii
-
Honolulu, Hawaii, Stati Uniti, 96813
- Queen's Medical Center
-
Honolulu, Hawaii, Stati Uniti, 96813
- Straub Clinic and Hospital
-
Honolulu, Hawaii, Stati Uniti, 96819
- Kaiser Permanente Moanalua Medical Center
-
Honolulu, Hawaii, Stati Uniti, 96813
- University of Hawaii
-
Honolulu, Hawaii, Stati Uniti, 96813
- Oncare Hawaii Inc-POB II
-
Honolulu, Hawaii, Stati Uniti, 96817-3169
- OnCare Hawaii-Liliha
-
Honolulu, Hawaii, Stati Uniti, 96817
- Oncare Hawaii Inc-Kuakini
-
Kailua, Hawaii, Stati Uniti, 96734
- Castle Medical Center
-
Lihue, Hawaii, Stati Uniti, 96766
- Wilcox Memorial Hospital and Kauai Medical Clinic
-
‘Aiea, Hawaii, Stati Uniti, 96701
- Pali Momi Medical Center
-
‘Aiea, Hawaii, Stati Uniti, 96701
- Oncare Hawaii Inc-Pali Momi
-
-
Idaho
-
Boise, Idaho, Stati Uniti, 83706
- Saint Alphonsus Regional Medical Center
-
-
Illinois
-
Bloomington, Illinois, Stati Uniti, 61701
- Saint Joseph Medical Center
-
Bloomington, Illinois, Stati Uniti, 61701
- Illinois CancerCare-Bloomington
-
Canton, Illinois, Stati Uniti, 61520
- Illinois CancerCare-Canton
-
Carbondale, Illinois, Stati Uniti, 62902
- Memorial Hospital of Carbondale
-
Carthage, Illinois, Stati Uniti, 62321
- Illinois CancerCare-Carthage
-
Centralia, Illinois, Stati Uniti, 62801
- Centralia Oncology Clinic
-
Chicago, Illinois, Stati Uniti, 60611
- Northwestern University
-
Chicago, Illinois, Stati Uniti, 60612
- University of Illinois
-
Decatur, Illinois, Stati Uniti, 62526
- Decatur Memorial Hospital
-
Decatur, Illinois, Stati Uniti, 62526
- Cancer Care Center of Decatur
-
Effingham, Illinois, Stati Uniti, 62401
- Crossroads Cancer Center
-
Eureka, Illinois, Stati Uniti, 61530
- Illinois CancerCare-Eureka
-
Galesburg, Illinois, Stati Uniti, 61401
- Illinois CancerCare Galesburg
-
Galesburg, Illinois, Stati Uniti, 61401
- Illinois CancerCare-Galesburg Cottage Plaza Office
-
Highland Park, Illinois, Stati Uniti, 60035
- Hematology Oncology Associates of Illinois-Highland Park
-
Hinsdale, Illinois, Stati Uniti, 60521
- Hinsdale Hematology Oncology Associates Incorporated
-
Kankakee, Illinois, Stati Uniti, 60901
- Presence Saint Mary's Hospital
-
Kewanee, Illinois, Stati Uniti, 61443
- Illinois CancerCare-Kewanee Clinic
-
Libertyville, Illinois, Stati Uniti, 60048
- North Shore Hematology Oncology
-
Macomb, Illinois, Stati Uniti, 61455
- Illinois CancerCare-Macomb
-
Maywood, Illinois, Stati Uniti, 60153
- Loyola University Medical Center
-
Moline, Illinois, Stati Uniti, 61265
- Garneau, Stewart C MD (UIA Investigator)
-
Moline, Illinois, Stati Uniti, 61265
- Porubcin, Michael MD (UIA Investigator)
-
Moline, Illinois, Stati Uniti, 61265
- Spector, David MD (UIA Investigator)
-
Moline, Illinois, Stati Uniti, 61265
- Trinity Medical Center
-
Monmouth, Illinois, Stati Uniti, 61462
- Illinois CancerCare-Monmouth
-
Mount Vernon, Illinois, Stati Uniti, 62864
- Good Samaritan Regional Health Center
-
Niles, Illinois, Stati Uniti, 60714
- Illinois Cancer Specialists-Niles
-
Normal, Illinois, Stati Uniti, 61761
- Community Cancer Center Foundation
-
Ottawa, Illinois, Stati Uniti, 61350
- Illinois CancerCare-Ottawa Clinic
-
Ottawa, Illinois, Stati Uniti, 61350
- Ottawa Regional Hospital and Healthcare Center
-
Pekin, Illinois, Stati Uniti, 61554
- Pekin Cancer Treatment Center
-
Pekin, Illinois, Stati Uniti, 61603
- Illinois CancerCare-Pekin
-
Peoria, Illinois, Stati Uniti, 61637
- OSF Saint Francis Medical Center
-
Peoria, Illinois, Stati Uniti, 61615
- Illinois CancerCare-Peoria
-
Peoria, Illinois, Stati Uniti, 61614
- Proctor Hospital
-
Peoria, Illinois, Stati Uniti, 61603
- Methodist Medical Center of Illinois
-
Peoria, Illinois, Stati Uniti, 61615
- Illinois Oncology Research Association CCOP
-
Peru, Illinois, Stati Uniti, 61354
- Illinois CancerCare-Peru
-
Princeton, Illinois, Stati Uniti, 61356
- Illinois CancerCare-Princeton
-
Rockford, Illinois, Stati Uniti, 61107
- SwedishAmerican Regional Cancer Center/ACT
-
Skokie, Illinois, Stati Uniti, 60076
- Hematology Oncology Associates of Illinois - Skokie
-
Springfield, Illinois, Stati Uniti, 62781-0001
- Memorial Medical Center
-
-
Indiana
-
Indianapolis, Indiana, Stati Uniti, 46237
- Franciscan Saint Francis Health-Indianapolis
-
Richmond, Indiana, Stati Uniti, 47374
- Reid Hospital and Health Care Services
-
-
Iowa
-
Ames, Iowa, Stati Uniti, 50010
- Mary Greeley Medical Center
-
Ames, Iowa, Stati Uniti, 50010
- McFarland Clinic PC-William R Bliss Cancer Center
-
Bettendorf, Iowa, Stati Uniti, 52722
- Constantinou, Costas L MD (UIA Investigator)
-
Boone, Iowa, Stati Uniti, 50036
- McFarland Clinic PC-Boone
-
Clive, Iowa, Stati Uniti, 50325
- Mercy Cancer Center-West Lakes
-
Clive, Iowa, Stati Uniti, 50325
- Medical Oncology and Hematology Associates-West Des Moines
-
Des Moines, Iowa, Stati Uniti, 50309
- Iowa Methodist Medical Center
-
Des Moines, Iowa, Stati Uniti, 50314
- Mercy Medical Center - Des Moines
-
Des Moines, Iowa, Stati Uniti, 50309
- Medical Oncology and Hematology Associates-Des Moines
-
Des Moines, Iowa, Stati Uniti, 50316
- Iowa Lutheran Hospital
-
Des Moines, Iowa, Stati Uniti, 50314
- Medical Oncology and Hematology Associates-Laurel
-
Des Moines, Iowa, Stati Uniti, 50309
- Iowa Oncology Research Association CCOP
-
Jefferson, Iowa, Stati Uniti, 50129
- McFarland Clinic PC-Jefferson
-
Marshalltown, Iowa, Stati Uniti, 50158
- McFarland Clinic PC-Marshalltown
-
Sioux City, Iowa, Stati Uniti, 51104
- Saint Luke's Regional Medical Center
-
Sioux City, Iowa, Stati Uniti, 51101
- Siouxland Hematology Oncology Associates
-
Sioux City, Iowa, Stati Uniti, 51104
- Mercy Medical Center-Sioux City
-
West Des Moines, Iowa, Stati Uniti, 50266-7700
- Methodist West Hospital
-
West Des Moines, Iowa, Stati Uniti, 50266
- Mercy Medical Center-West Lakes
-
-
Kansas
-
Chanute, Kansas, Stati Uniti, 66720
- Cancer Center of Kansas - Chanute
-
Dodge City, Kansas, Stati Uniti, 67801
- Cancer Center of Kansas - Dodge City
-
El Dorado, Kansas, Stati Uniti, 67042
- Cancer Center of Kansas - El Dorado
-
Fort Scott, Kansas, Stati Uniti, 66701
- Cancer Center of Kansas - Fort Scott
-
Independence, Kansas, Stati Uniti, 67301
- Cancer Center of Kansas-Independence
-
Kingman, Kansas, Stati Uniti, 67068
- Cancer Center of Kansas-Kingman
-
Lawrence, Kansas, Stati Uniti, 66044
- Lawrence Memorial Hospital
-
Liberal, Kansas, Stati Uniti, 67901
- Cancer Center of Kansas-Liberal
-
Manhattan, Kansas, Stati Uniti, 66502
- Cancer Center of Kansas-Manhattan
-
McPherson, Kansas, Stati Uniti, 67460
- Cancer Center of Kansas - McPherson
-
Newton, Kansas, Stati Uniti, 67114
- Cancer Center of Kansas - Newton
-
Parsons, Kansas, Stati Uniti, 67357
- Cancer Center of Kansas - Parsons
-
Pratt, Kansas, Stati Uniti, 67124
- Cancer Center of Kansas - Pratt
-
Salina, Kansas, Stati Uniti, 67401
- Cancer Center of Kansas - Salina
-
Wellington, Kansas, Stati Uniti, 67152
- Cancer Center of Kansas - Wellington
-
Wichita, Kansas, Stati Uniti, 67208
- Cancer Center of Kansas-Wichita Medical Arts Tower
-
Wichita, Kansas, Stati Uniti, 67208
- Associates In Womens Health
-
Wichita, Kansas, Stati Uniti, 67214
- Cancer Center of Kansas - Main Office
-
Wichita, Kansas, Stati Uniti, 67214
- Via Christi Regional Medical Center
-
Wichita, Kansas, Stati Uniti, 67214
- Wichita CCOP
-
Winfield, Kansas, Stati Uniti, 67156
- Cancer Center of Kansas - Winfield
-
-
Kentucky
-
Crestview Hills, Kentucky, Stati Uniti, 41017
- Oncology Hematology Care Incorporated
-
-
Louisiana
-
Baton Rouge, Louisiana, Stati Uniti, 70809
- Ochsner Health Center-Summa
-
New Orleans, Louisiana, Stati Uniti, 70121
- Ochsner Medical Center Jefferson
-
-
Massachusetts
-
Boston, Massachusetts, Stati Uniti, 02118
- Boston Medical Center
-
Burlington, Massachusetts, Stati Uniti, 01805
- Lahey Hospital and Medical Center
-
-
Michigan
-
Adrian, Michigan, Stati Uniti, 49221
- Bixby Medical Center
-
Adrian, Michigan, Stati Uniti, 49221
- Hickman Cancer Center
-
Ann Arbor, Michigan, Stati Uniti, 48106-0995
- Saint Joseph Mercy Hospital
-
Ann Arbor, Michigan, Stati Uniti, 48106
- Michigan Cancer Research Consortium Community Clinical Oncology Program
-
Ann Arbor, Michigan, Stati Uniti, 48109
- University of Michigan University Hospital
-
Dearborn, Michigan, Stati Uniti, 48124
- Oakwood Hospital
-
Detroit, Michigan, Stati Uniti, 48236
- Saint John Hospital and Medical Center
-
Flint, Michigan, Stati Uniti, 48502
- Hurley Medical Center
-
Flint, Michigan, Stati Uniti, 48503
- Genesys Hurley Cancer Institute
-
Jackson, Michigan, Stati Uniti, 49201
- Allegiance Health
-
Kalamazoo, Michigan, Stati Uniti, 49007
- West Michigan Cancer Center
-
Kalamazoo, Michigan, Stati Uniti, 49007
- Bronson Methodist Hospital
-
Kalamazoo, Michigan, Stati Uniti, 49001
- Borgess Medical Center
-
Lansing, Michigan, Stati Uniti, 48912
- Sparrow Hospital
-
Livonia, Michigan, Stati Uniti, 48154
- Saint Mary Mercy Hospital
-
Monroe, Michigan, Stati Uniti, 48162
- Mercy Memorial Hospital
-
Monroe, Michigan, Stati Uniti, 48162
- Community Cancer Center of Monroe
-
Pontiac, Michigan, Stati Uniti, 48341-2985
- Saint Joseph Mercy Oakland
-
Port Huron, Michigan, Stati Uniti, 48060
- Saint Joseph Mercy Port Huron
-
Saginaw, Michigan, Stati Uniti, 48601
- Saint Mary's of Michigan
-
Warren, Michigan, Stati Uniti, 48093
- Saint John Macomb-Oakland Hospital
-
-
Minnesota
-
Burnsville, Minnesota, Stati Uniti, 55337
- Fairview Ridges Hospital
-
Coon Rapids, Minnesota, Stati Uniti, 55433
- Mercy Hospital
-
Edina, Minnesota, Stati Uniti, 55435
- Fairview-Southdale Hospital
-
Fridley, Minnesota, Stati Uniti, 55432
- Unity Hospital
-
Hutchinson, Minnesota, Stati Uniti, 55350
- Hutchinson Area Health Care
-
Maplewood, Minnesota, Stati Uniti, 55109
- Saint John's Hospital - Healtheast
-
Maplewood, Minnesota, Stati Uniti, 55109
- Minnesota Oncology Hematology PA-Maplewood
-
Minneapolis, Minnesota, Stati Uniti, 55415
- Hennepin County Medical Center
-
Minneapolis, Minnesota, Stati Uniti, 55407
- Abbott-Northwestern Hospital
-
New Ulm, Minnesota, Stati Uniti, 56073
- New Ulm Medical Center
-
Robbinsdale, Minnesota, Stati Uniti, 55422
- North Memorial Medical Health Center
-
Saint Louis Park, Minnesota, Stati Uniti, 55416
- Park Nicollet Clinic - Saint Louis Park
-
Saint Louis Park, Minnesota, Stati Uniti, 55416
- Metro-Minnesota CCOP
-
Saint Paul, Minnesota, Stati Uniti, 55101
- Regions Hospital
-
Saint Paul, Minnesota, Stati Uniti, 55102
- United Hospital
-
Shakopee, Minnesota, Stati Uniti, 55379
- Saint Francis Regional Medical Center
-
Stillwater, Minnesota, Stati Uniti, 55082
- Lakeview Hospital
-
Waconia, Minnesota, Stati Uniti, 55387
- Ridgeview Medical Center
-
Willmar, Minnesota, Stati Uniti, 56201
- Rice Memorial Hospital
-
Woodbury, Minnesota, Stati Uniti, 55125
- Minnesota Oncology and Hematology PA-Woodbury
-
-
Missouri
-
Bolivar, Missouri, Stati Uniti, 65613
- Central Care Cancer Center-Carrie J Babb Cancer Center
-
Branson, Missouri, Stati Uniti, 65616
- CoxHealth Cancer Center
-
Cape Girardeau, Missouri, Stati Uniti, 63703
- Saint Francis Medical Center
-
Cape Girardeau, Missouri, Stati Uniti, 63703
- Southeast Cancer Center
-
Jefferson City, Missouri, Stati Uniti, 65109
- Capital Region Medical Center-Goldschmidt Cancer Center
-
Rolla, Missouri, Stati Uniti, 65401
- Phelps County Regional Medical Center
-
Rolla, Missouri, Stati Uniti, 65401
- Saint John's Clinic-Rolla-Cancer and Hematology
-
Springfield, Missouri, Stati Uniti, 65807
- CoxHealth South Hospital
-
Springfield, Missouri, Stati Uniti, 65804
- Mercy Hospital Springfield
-
Springfield, Missouri, Stati Uniti, 65802
- Ozark Health Ventures LLC dba Cancer Research for The Ozarks Springfield
-
St Louis, Missouri, Stati Uniti, 63131
- Missouri Baptist Medical Center
-
St Louis, Missouri, Stati Uniti, 63109
- Saint Louis Cancer and Breast Institute-South City
-
St Louis, Missouri, Stati Uniti, 63141
- Saint John's Mercy Medical Center
-
-
Nebraska
-
Omaha, Nebraska, Stati Uniti, 68114
- Nebraska Methodist Hospital
-
-
Nevada
-
Las Vegas, Nevada, Stati Uniti, 89106
- Nevada Cancer Research Foundation CCOP
-
-
New Jersey
-
Camden, New Jersey, Stati Uniti, 08103
- Cooper Hospital University Medical Center
-
Mount Holly, New Jersey, Stati Uniti, 08060
- Fox Chase Cancer Center at Virtua Memorial Hospital of Burlington County
-
Voorhees Township, New Jersey, Stati Uniti, 08043
- Virtua West Jersey Hospital Voorhees
-
-
New York
-
Albany, New York, Stati Uniti, 12208
- New York Oncology Hematology PC -Albany Medical Center
-
Albany, New York, Stati Uniti, 12206
- New York Oncology Hematology PC - Albany
-
Amsterdam, New York, Stati Uniti, 12010
- New York Oncology Hematology PC - Amsterdam
-
Hudson, New York, Stati Uniti, 12534
- New York Oncology Hematology PC-Hudson
-
Latham, New York, Stati Uniti, 12110
- New York Oncology Hematology PC - Latham
-
Rexford, New York, Stati Uniti, 12148
- New York Oncology Hematology PC - Rexford
-
Rochester, New York, Stati Uniti, 14642
- University of Rochester
-
The Bronx, New York, Stati Uniti, 10467-2490
- Montefiore Medical Center
-
The Bronx, New York, Stati Uniti, 10461
- Montefiore Medical Center-Weiler Division
-
Troy, New York, Stati Uniti, 12180
- New York Oncology Hematology PC - Troy
-
-
North Carolina
-
Kinston, North Carolina, Stati Uniti, 28501
- Kinston Medical Specialists PA
-
Statesville, North Carolina, Stati Uniti, 28677
- Iredell Memorial Hospital
-
-
Ohio
-
Akron, Ohio, Stati Uniti, 44307
- Akron General Medical Center
-
Beachwood, Ohio, Stati Uniti, 44122
- Cleveland Clinic Cancer Center Beachwood
-
Belpre, Ohio, Stati Uniti, 45714
- Strecker Cancer Center-Belpre
-
Bowling Green, Ohio, Stati Uniti, 43402
- Toledo Clinic Cancer Centers-Bowling Green
-
Chillicothe, Ohio, Stati Uniti, 45601
- Adena Regional Medical Center
-
Cincinnati, Ohio, Stati Uniti, 45267
- University of Cincinnati
-
Cincinnati, Ohio, Stati Uniti, 45230
- Oncology Hematology Care Inc - Anderson
-
Cincinnati, Ohio, Stati Uniti, 45236
- Oncology Hematology Care Inc - Kenwood
-
Cincinnati, Ohio, Stati Uniti, 45219
- Oncology and Hematology Care Incorporated
-
Cincinnati, Ohio, Stati Uniti, 45242
- Oncology and Hematology Care Inc - Blue Ash
-
Cincinnati, Ohio, Stati Uniti, 45248
- Oncology Hematology Care Inc - Western Hills
-
Cleveland, Ohio, Stati Uniti, 44106
- Case Western Reserve University
-
Cleveland, Ohio, Stati Uniti, 44195
- Cleveland Clinic Foundation
-
Columbus, Ohio, Stati Uniti, 43214
- Riverside Methodist Hospital
-
Columbus, Ohio, Stati Uniti, 43219
- The Mark H Zangmeister Center
-
Columbus, Ohio, Stati Uniti, 43210
- Ohio State University Medical Center
-
Columbus, Ohio, Stati Uniti, 43214
- Columbus Oncology and Hematology Associates Inc
-
Columbus, Ohio, Stati Uniti, 43228
- Doctors Hospital
-
Columbus, Ohio, Stati Uniti, 43215
- Grant Medical Center
-
Columbus, Ohio, Stati Uniti, 43222
- Mount Carmel Health Center West
-
Columbus, Ohio, Stati Uniti, 43215
- Columbus CCOP
-
Dayton, Ohio, Stati Uniti, 45406
- Good Samaritan Hospital - Dayton
-
Dayton, Ohio, Stati Uniti, 45409
- Miami Valley Hospital
-
Dayton, Ohio, Stati Uniti, 45415
- Samaritan North Health Center
-
Dayton, Ohio, Stati Uniti, 45405
- Grandview Hospital
-
Dayton, Ohio, Stati Uniti, 45420
- Dayton CCOP
-
Delaware, Ohio, Stati Uniti, 43015
- Delaware Health Center-Grady Cancer Center
-
Delaware, Ohio, Stati Uniti, 43015
- Delaware Radiation Oncology
-
Delaware, Ohio, Stati Uniti, 43015
- Grady Memorial Hospital
-
Elyria, Ohio, Stati Uniti, 44035
- Mercy Cancer Center-Elyria
-
Elyria, Ohio, Stati Uniti, 44035
- Hematology Oncology Center Incorporated
-
Fairfield, Ohio, Stati Uniti, 45014
- Oncology Hematology Care Inc
-
Findlay, Ohio, Stati Uniti, 45840
- Blanchard Valley Hospital
-
Franklin, Ohio, Stati Uniti, 45005-1066
- Atrium Medical Center-Middletown Regional Hospital
-
Greenville, Ohio, Stati Uniti, 45331
- Wayne Hospital
-
Independence, Ohio, Stati Uniti, 44131
- Cleveland Clinic Cancer Center Independence
-
Kettering, Ohio, Stati Uniti, 45429
- Kettering Medical Center
-
Lancaster, Ohio, Stati Uniti, 43130
- Fairfield Medical Center
-
Lancaster, Ohio, Stati Uniti, 43130
- Lancaster Radiation Oncology
-
Lima, Ohio, Stati Uniti, 45801
- Saint Rita's Medical Center
-
Lima, Ohio, Stati Uniti, 45804
- Lima Memorial Hospital
-
Marietta, Ohio, Stati Uniti, 45750
- Marietta Memorial Hospital
-
Maumee, Ohio, Stati Uniti, 43537
- Toledo Clinic Cancer Centers-Maumee
-
Maumee, Ohio, Stati Uniti, 43537
- Toledo Radiation Oncology at Northwest Ohio Onocolgy Center
-
Mayfield Heights, Ohio, Stati Uniti, 44124
- Hillcrest Hospital Cancer Center
-
Mount Vernon, Ohio, Stati Uniti, 43050
- Knox Community Hospital
-
Newark, Ohio, Stati Uniti, 43055
- Licking Memorial Hospital
-
Newark, Ohio, Stati Uniti, 43055
- Newark Radiation Oncology
-
Oregon, Ohio, Stati Uniti, 43616
- Saint Charles Hospital
-
Oregon, Ohio, Stati Uniti, 43616
- Toledo Clinic Cancer Centers-Oregon
-
Portsmouth, Ohio, Stati Uniti, 45662
- Southern Ohio Medical Center
-
Sandusky, Ohio, Stati Uniti, 44870
- North Coast Cancer Care
-
Springfield, Ohio, Stati Uniti, 45505
- Springfield Regional Medical Center
-
Strongsville, Ohio, Stati Uniti, 44136
- Cleveland Clinic Cancer Center-Strongsville
-
Sylvania, Ohio, Stati Uniti, 43560
- Flower Hospital
-
Tiffin, Ohio, Stati Uniti, 44883
- Mercy Hospital of Tiffin
-
Toledo, Ohio, Stati Uniti, 43608
- Saint Vincent Mercy Medical Center
-
Toledo, Ohio, Stati Uniti, 43623
- Toledo Clinic Cancer Centers-Toledo
-
Toledo, Ohio, Stati Uniti, 43614
- University of Toledo
-
Toledo, Ohio, Stati Uniti, 43617
- Toledo Community Hospital Oncology Program CCOP
-
Toledo, Ohio, Stati Uniti, 43606
- The Toledo Hospital/Toledo Children's Hospital
-
Toledo, Ohio, Stati Uniti, 43623
- Mercy Saint Anne Hospital
-
Troy, Ohio, Stati Uniti, 45373
- Upper Valley Medical Center
-
Wauseon, Ohio, Stati Uniti, 43567
- Fulton County Health Center
-
Westerville, Ohio, Stati Uniti, 43081
- Saint Ann's Hospital
-
Xenia, Ohio, Stati Uniti, 45385
- Greene Memorial Hospital
-
Zanesville, Ohio, Stati Uniti, 43701
- Genesis HealthCare System
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Stati Uniti, 73104
- University of Oklahoma Health Sciences Center
-
Tulsa, Oklahoma, Stati Uniti, 74146
- Tulsa Cancer Institute
-
-
Pennsylvania
-
Danville, Pennsylvania, Stati Uniti, 17822-2001
- Geisinger Medical Center
-
Hazleton, Pennsylvania, Stati Uniti, 18201
- Geisinger Medical Center-Cancer Center Hazleton
-
Hershey, Pennsylvania, Stati Uniti, 17033-0850
- Penn State Milton S Hershey Medical Center
-
Lewisburg, Pennsylvania, Stati Uniti, 17837
- Geisinger Medical Oncology at Evangelical Community Hospital
-
Philadelphia, Pennsylvania, Stati Uniti, 19111
- Fox Chase Cancer Center
-
Philadelphia, Pennsylvania, Stati Uniti, 19107
- Thomas Jefferson University Hospital
-
Pottsville, Pennsylvania, Stati Uniti, 17901
- Geisinger Medical Oncology-Pottsville
-
State College, Pennsylvania, Stati Uniti, 16801
- Geisinger Medical Group
-
West Reading, Pennsylvania, Stati Uniti, 19611
- Reading Hospital
-
Wilkes-Barre, Pennsylvania, Stati Uniti, 18711
- Geisinger Wyoming Valley
-
-
South Carolina
-
Greenville, South Carolina, Stati Uniti, 29605
- Greenville Health System Cancer Institute-Butternut
-
Greenville, South Carolina, Stati Uniti, 29615
- Greenville Health System Cancer Institute/Greenville CCOP
-
Greer, South Carolina, Stati Uniti, 29650
- Greenville Health System Cancer Institute-Greer
-
-
Tennessee
-
Nashville, Tennessee, Stati Uniti, 37232-6838
- Vanderbilt Cancer Center
-
-
Virginia
-
Fredericksburg, Virginia, Stati Uniti, 22401
- Fredericksburg Oncology Inc
-
-
Wisconsin
-
La Crosse, Wisconsin, Stati Uniti, 54601
- Gundersen Lutheran
-
Madison, Wisconsin, Stati Uniti, 53792
- University of Wisconsin Hospital and Clinics
-
Milwaukee, Wisconsin, Stati Uniti, 53226
- Froedtert and the Medical College of Wisconsin
-
New Richmond, Wisconsin, Stati Uniti, 54017
- Cancer Center of Western Wisconsin
-
-
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
-
Patient must have histologically or pathologically confirmed locally unresectable or metastatic low or intermediate grade pancreatic neuroendocrine tumor
-
Patient must have measurable disease by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 criteria; baseline measurements and evaluations of all sites of disease must be obtained <= 4 weeks prior to randomization and must be acquired by multiphasic CT or contrast magnetic resonance imaging (MRI)
-
Date of last documented disease progression must be within 12 months from date of randomization
-
Prior everolimus and/or sunitinib therapy is allowed, so long as it was discontinued >= 4 weeks prior to randomization
-
Concurrent somatostatin analogues are allowed provided that patients
- Have been on a stable dose for 8 weeks and
- Have documented disease progression on that dose
-
Chemoembolization is allowed if ≥ 4 weeks from study entry. There are 2 possible scenarios:
- If patient has hepatic disease only: they need to have progressed in the liver since chemoembolization and have measurable disease by RECIST 1.1 in order to be eligible.
- If patient has hepatic and extrahepatic disease: they will need to have progressed inside OR outside the liver and have measureable disease by RECIST 1.1 in order to be eligible.
-
Leukocytes >= 3,000/mm^3
-
Absolute neutrophil count >= 1,500/mm^3
-
Hemoglobin >= 9 g/dL
-
Platelets >= 100,000/mm^3
-
Total bilirubin <= institutional upper limit of normal (ULN) or <= 1.5 X institutional ULN (if the patient has liver metastases)
-
Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT])/alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) <= 3 X institutional ULN or (<= 5 X institutional ULN if the patient has liver metastases)
-
Serum creatinine <= 1.5 X institutional ULN
-
Patient must have Eastern Cooperative Oncology Group (ECOG) performance status 0-1
-
Patient must have life expectancy >= 12 weeks all females of childbearing potential must have a blood test or urine study within =< 2 weeks prior to randomization to rule out pregnancy; a female of childbearing potential is any woman, regardless of sexual orientation or whether they have undergone tubal ligation, who meets the following criteria:
- Has not undergone a hysterectomy or bilateral oophorectomy; or
- Has not been naturally postmenopausal for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months)
-
Women of childbearing potential and sexually active males must be strongly advised to use an accepted and effective method of contraception or to abstain from sexual intercourse for the duration of their participation in the study; should a woman become pregnant while participating in this study, she should inform her treating physician immediately; if a man impregnates a woman while participating in this study, he should inform his treating physician immediately
-
Patient must be able to swallow pills
-
Patient must be able to tolerate CT or magnetic resonance (MR) imaging including contrast agents as required for their treatment and the protocol
Exclusion Criteria:
-
Small cell carcinoma
-
Prior temozolomide, dacarbazine (DTIC), or capecitabine, or 5-FU (fluorouracil) therapy
-
Receiving any other investigational agents while on study treatment
-
Receiving Coumadin while on treatment; other anticoagulants are allowed
-
Patients with either clinically apparent central nervous system metastases or carcinomatous meningitis are ineligible
-
Active or uncontrolled infection or serious medical or psychiatric illness
-
History of allergic reactions attributed to compounds of similar chemical or biologic composition to temozolomide or capecitabine
-
Absorption issues that would limit the ability to absorb study agents
-
Patients with a history of the following within 12 months of study entry:
- Arterial thromboembolic events
- Unstable angina
- Myocardial Infarction
-
Symptomatic peripheral vascular disease
-
Patients with previous or concurrent malignancy; exceptions are made for patients who meet any of the following conditions:
- Non-melanoma skin cancer, in situ cervical cancer, or breast cancer in situ OR
- Prior malignancy completely excised or removed and patient has been continuously disease free for > 5 years OR
- Prior malignancy cured by non-surgical modalities and patient has been continuously disease free for > 5 years
-
Pregnant or breast-feeding
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Numero di armi
Armi e interventi
Gruppo di partecipanti / ArmGruppo di partecipanti / Arm |
Intervento / TrattamentoIntervento / Trattamento |
|---|---|
|
Sperimentale: Arm A (temozolomide)
Patients receive temozolomide PO QD on days 1-5. Treatment repeats every 28 days for up to 13 courses in the absence of disease progression or unacceptable toxicity. |
Given PO
Altri nomi:
|
|
Sperimentale: Arm B (temozolomide and capecitabine)
Patients receive capecitabine PO BID on days 1-14 and temozolomide PO QD on days 10-14. Treatment repeats every 28 days for up to 13 courses in the absence of disease progression or unacceptable toxicity. |
Given PO
Altri nomi:
Given PO
Altri nomi:
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Progression-free Survival
Lasso di tempo: Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
Progression-free survival (PFS) is defined as the time from randomization to progression or death without evidence of progression. Progression was evaluated using the revised Response Evaluation Criteria in Solid Tumors (RECIST) guideline (version 1.1) and defined as at least a 20% increase in the sum of the diameters of target lesions, taking as reference the smallest sum on study (this includes the baseline sum if that is the smallest on study). In addition to the relative increase of 20%, the sum must also demonstrate an absolute increase of at least 5 mm. Kaplan-Meier method was used to estimate PFS. |
Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
Misure di risultato secondarie
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Proportion of Patients With Response
Lasso di tempo: Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
Response was evaluated using the revised Response Evaluation Criteria in Solid Tumors (RECIST) guideline (version 1.1) and defined as either complete response (CR) or partial response (PR). CR is defined as disappearance of all target lesions. Any pathological lymph nodes (whether target or non-target) must have reduction in short axis to < 10 mm. PR is defined as at least a 30% decrease in the sum of the diameters of target lesions, taking as reference the baseline sum diameters. |
Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
|
Overall Survival
Lasso di tempo: Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
Overall survival is defined as time from randomization to death or date last known alive. |
Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
|
Association Between Methyl Guanine Methyltransferase (MGMT) Status by Immunohistochemistry (IHC) and Response
Lasso di tempo: Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
Response was evaluated using the revised Response Evaluation Criteria in Solid Tumors (RECIST) guideline (version 1.1) and defined as either complete response (CR) or partial response (PR). CR is defined as disappearance of all target lesions. PR is defined as at least a 30% decrease in the sum of the diameters of target lesions, taking as reference the baseline sum diameters. MGMT status was determined by IHC using paraffin-embedded sections of 4µm. A score (H-score) was generated based on the findings and scoring was performed by two pathologists. This H-score ranges from 0 (no staining in the tumor) to 300 (diffuse intense staining of the tumor). The highest score was used if there was disagreement. H-scores were grouped into 3 standard categories for MGMT status: Category 1 - <=50 Category 2 - 51-100 Category 3 - >100 |
Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
|
Association Between Methyl Guanine Methyltransferase (MGMT) Status by Promoter Methylation and Response
Lasso di tempo: Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
Response was evaluated using the revised Response Evaluation Criteria in Solid Tumors (RECIST) guideline (version 1.1) and defined as either complete response (CR) or partial response (PR). CR is defined as disappearance of all target lesions. Any pathological lymph nodes (whether target or non-target) must have reduction in short axis to < 10 mm. PR is defined as at least a 30% decrease in the sum of the diameters of target lesions, taking as reference the baseline sum diameters. MGMT status is determined by promoter methylation, a clinically validated methylation-specific polymerase chain reaction (PCR) analysis. A tumor sample is considered positive for MGMT promoter methylation if an 80bp band is detected in the methylated PCR reaction. It would be considered MGMT negative if an 80bp band is not detected in the methylated PCR reaction. |
Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
Collaboratori e investigatori
Sponsor
Sponsor
Collaboratori
Collaboratori
Investigatori
Investigatori
- Investigatore principale: Pamela Kunz, ECOG-ACRIN Cancer Research Group
Pubblicazioni e link utili
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Inizio studio
Completamento primario (Effettivo)
Completamento primario
Completamento dello studio (Effettivo)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stimato)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
- Malattie del sistema endocrino
- Neoplasie per sede
- Neoplasie
- Neoplasie per tipo istologico
- Neoplasie dell'apparato digerente
- Malattie dell'apparato digerente
- Neoplasie delle ghiandole endocrine
- Malattie pancreatiche
- Neoplasie, ghiandolari ed epiteliali
- Adenocarcinoma
- Adenoma
- Carcinoma
- Tumori neuroectodermici
- Neoplasie, cellule germinali ed embrionali
- Tumori neuroendocrini
- Carcinoma, neuroendocrino
- Neoplasie pancreatiche
- Adenoma, cellula dell'isolotto
- Carcinoma, cellula dell'isolotto
- Gastrinoma
- Insulinoma
- Glucagonoma
- Somatostatinoma
- Prodotti chimici organici
- Composti eterociclici, 1-anello
- Composti eterociclici
- Azoli
- Acidi nucleici, nucleotidi e nucleosidi
- Dacarbazine
- Triazenes
- Imidazoli
- Deossictidina
- Citidina
- Nucleosidi di pirimidina
- Pirimidine
- Nucleosidi
- Uracile
- Pirimidinoni
- Deossiribonucleosidi
- Fluorouracile
- Temozolomide
- Capecitabina
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- E2211
- U10CA180820 (Sovvenzione/contratto NIH degli Stati Uniti)
- U10CA021115 (Sovvenzione/contratto NIH degli Stati Uniti)
- E2211 (Altro identificatore: ECOG-ACRIN Cancer Research Group)
- NCI-2012-02007 (Identificatore di registro: CTRP (Clinical Trial Reporting Program))
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
Individual participant data may be made available upon request as per the ECOG-ACRIN Data Sharing Policy.
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
prodotto fabbricato ed esportato dagli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .